{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:20:01Z","timestamp":1746591601958,"version":"3.40.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03942-8","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T18:39:17Z","timestamp":1746556757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases"],"prefix":"10.1186","volume":"25","author":[{"given":"Eva","family":"Theswet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Br\u00fccker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kreienb\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain M.","family":"Schoepfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Straumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Biedermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"3942_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF01296781","volume":"38","author":"SE Attwood","year":"1993","unstructured":"Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109\u201316. https:\/\/doi.org\/10.1007\/BF01296781","journal-title":"Dig Dis Sci"},{"key":"3942_CR2","first-page":"1419","volume":"124","author":"A Straumann","year":"1994","unstructured":"Straumann A, Spichtin HP, Bernoulli R, Loosli J, V\u00f6gtlin J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr. 1994;124:1419\u201329.","journal-title":"Schweiz Med Wochenschr"},{"key":"3942_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.anai.2017.02.006","volume":"118","author":"J Gonz\u00e1lez-Cervera","year":"2017","unstructured":"Gonz\u00e1lez-Cervera J, Arias \u00c1, Redondo-Gonz\u00e1lez O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ. Association between atopic manifestations and eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2017;118:582\u2013e5902. https:\/\/doi.org\/10.1016\/j.anai.2017.02.006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"3942_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.14309\/ajg.0000000000001777","volume":"117","author":"AJ Bredenoord","year":"2022","unstructured":"Bredenoord AJ, Patel K, Schoepfer AM, Dellon ES, Chehade M, Aceves SS, et al. Disease burden and unmet need in eosinophilic esophagitis. Am J Gastroenterol. 2022;117:1231\u201341. https:\/\/doi.org\/10.14309\/ajg.0000000000001777","journal-title":"Am J Gastroenterol"},{"key":"3942_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.14309\/ajg.0000000000001950","volume":"117","author":"FR Murray","year":"2022","unstructured":"Murray FR, Kreienbuehl AS, Greuter T, Nennstiel S, Safroneeva E, Saner C, et al. Diagnostic delay in patients with eosinophilic esophagitis has not changed since the first description 30 years ago: diagnostic delay in eosinophilic esophagitis. Am J Gastroenterol. 2022;117:1772\u20139. https:\/\/doi.org\/10.14309\/ajg.0000000000001950","journal-title":"Am J Gastroenterol"},{"key":"3942_CR6","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ueg2.12092","volume":"9","author":"D Melgaard","year":"2021","unstructured":"Melgaard D, Westmark S, Laurberg PT, Krarup AL. A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education - a population-based cross-sectional study of incidence, diagnostic process and complications of eosinophilic oesophagitis in the North Denmark region. United Eur Gastroenterol J. 2021;9:688\u201398. https:\/\/doi.org\/10.1002\/ueg2.12092","journal-title":"United Eur Gastroenterol J"},{"key":"3942_CR7","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.cgh.2018.01.028","volume":"16","author":"CC Reed","year":"2018","unstructured":"Reed CC, Koutlas NT, Robey BS, Hansen J, Dellon ES. Prolonged time to diagnosis of eosinophilic esophagitis despite increasing knowledge of the disease. Clin Gastroenterol Hepatol. 2018;16:1667\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2018.01.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3942_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","volume":"113","author":"MJ Warners","year":"2018","unstructured":"Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smout AJPM, Bredenoord AJ. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. Am J Gastroenterol. 2018;113:836\u201344. https:\/\/doi.org\/10.1038\/s41395-018-0052-5","journal-title":"Am J Gastroenterol"},{"key":"3942_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MCG.0000000000000297","volume":"50","author":"S Lipka","year":"2016","unstructured":"Lipka S, Kumar A, Richter JE. Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter. J Clin Gastroenterol. 2016;50:134\u201340. https:\/\/doi.org\/10.1097\/MCG.0000000000000297","journal-title":"J Clin Gastroenterol"},{"key":"3942_CR10","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","volume":"145","author":"AM Schoepfer","year":"2013","unstructured":"Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon H, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230\u2013e12362. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.015","journal-title":"Gastroenterology"},{"key":"3942_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ueg2.12216","volume":"10","author":"L Bon","year":"2022","unstructured":"Bon L, Safroneeva E, Bussmann C, Biedermann L, Schreiner P, Vavricka SR, et al. Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long\u2010term management of eosinophilic esophagitis. United Eur Gastroenterol J. 2022;10:308\u201318. https:\/\/doi.org\/10.1002\/ueg2.12216","journal-title":"United Eur Gastroenterol J"},{"key":"3942_CR12","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/all.12455","volume":"69","author":"T Kuchen","year":"2014","unstructured":"Kuchen T, Straumann A, Safroneeva E, Romero Y, Bussmann C, Vavricka S, et al. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. Allergy. 2014;69:1248\u201354. https:\/\/doi.org\/10.1111\/all.12455","journal-title":"Allergy"},{"key":"3942_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.14309\/ajg.0000000000000597","volume":"115","author":"CC Reed","year":"2020","unstructured":"Reed CC, Corder SR, Kim E, Sanders E, Tappata M, Eluri S, et al. Psychiatric comorbidities and psychiatric medication use are highly prevalent in patients with eosinophilic esophagitis and associate with clinical presentation. Am J Gastroenterol. 2020;115:853\u20138. https:\/\/doi.org\/10.14309\/ajg.0000000000000597","journal-title":"Am J Gastroenterol"},{"key":"3942_CR14","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1053\/j.gastro.2021.06.023","volume":"161","author":"TH Taft","year":"2021","unstructured":"Taft TH, Carlson DA, Simons M, Zavala S, Hirano I, Gonsalves N, et al. Esophageal hypervigilance and symptom-specific anxiety in patients with eosinophilic esophagitis. Gastroenterology. 2021;161:1133\u201344. https:\/\/doi.org\/10.1053\/j.gastro.2021.06.023","journal-title":"Gastroenterology"},{"key":"3942_CR15","doi-asserted-by":"publisher","unstructured":"de Rooij WE, Evertsz\u2019 B, Lei F, Bredenoord A. Mental distress among adult patients with eosinophilic esophagitis. Neurogastroenterology Motil. 2021;33. https:\/\/doi.org\/10.1111\/nmo.14069","DOI":"10.1111\/nmo.14069"},{"key":"3942_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5217\/ir.2019.00135","volume":"19","author":"R Keller","year":"2021","unstructured":"Keller R, Mazurak N, Fantasia L, Fusco S, Malek NP, Wehkamp J, et al. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res. 2021;19:45\u201352. https:\/\/doi.org\/10.5217\/ir.2019.00135","journal-title":"Intest Res"},{"key":"3942_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cgh.2011.05.016","volume":"9","author":"S Singh","year":"2011","unstructured":"Singh S, Blanchard A, Walker JR, Graff LA, Miller N, Bernstein CN. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2011;9:769\u201375. https:\/\/doi.org\/10.1016\/j.cgh.2011.05.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3942_CR18","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1016\/j.cgh.2023.06.005","volume":"21","author":"JW Hahn","year":"2023","unstructured":"Hahn JW, Lee K, Shin J, Il, Cho SH, Turner S, Shin JU, et al. Global incidence and prevalence of eosinophilic esophagitis, 1976\u20132022: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:3270\u2013e328477. https:\/\/doi.org\/10.1016\/j.cgh.2023.06.005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3942_CR19","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","volume":"60","author":"M Bairkdar","year":"2021","unstructured":"Bairkdar M, Rossides M, Westerlind H, Hesselstrand R, Arkema EV, Holmqvist M. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology. 2021;60:3121\u201333. https:\/\/doi.org\/10.1093\/rheumatology\/keab190","journal-title":"Rheumatology"},{"key":"3942_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82:351\u20136. https:\/\/doi.org\/10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"3942_CR21","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1007\/s12325-020-01463-2","volume":"37","author":"RM Pokrzywinski","year":"2020","unstructured":"Pokrzywinski RM, Harding G, Brooks A, Goodwin B, Williams J. Documenting the journey of patients with eosinophilic esophagitis and the impact of the disease on patients and their caregivers: a cross-sectional, qualitative research study. Adv Ther. 2020;37:4458\u201378. https:\/\/doi.org\/10.1007\/s12325-020-01463-2","journal-title":"Adv Ther"},{"key":"3942_CR22","doi-asserted-by":"publisher","unstructured":"Shaheen NJ, Mukkada V, Eichinger CS, Schofield H, Todorova L, Falk GW. Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course. Dis Esophagus. 2018;31. https:\/\/doi.org\/10.1093\/dote\/doy015","DOI":"10.1093\/dote\/doy015"},{"key":"3942_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/2050640617707095","volume":"6","author":"AJ Lucendo","year":"2018","unstructured":"Lucendo AJ, Arias-Gonz\u00e1lez L, Molina-Infante J, Arias \u00c1. Determinant factors of quality of life in adult patients with eosinophilic esophagitis. United Eur Gastroenterol J. 2018;6:38\u201345. https:\/\/doi.org\/10.1177\/2050640617707095","journal-title":"United Eur Gastroenterol J"},{"key":"3942_CR24","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1007\/s00405-015-3757-8","volume":"272","author":"H Larsson","year":"2015","unstructured":"Larsson H, Bergman K, Finizia C, Johansson L, Bove M, Bergquist H. Erratum to: dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up. Eur Arch Otorhinolaryngol. 2015;272:3841\u20133841. https:\/\/doi.org\/10.1007\/s00405-015-3757-8","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3942_CR25","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cgh.2021.11.009","volume":"20","author":"P Schreiner","year":"2022","unstructured":"Schreiner P, Safroneeva E, Rossel J-B, Limacher A, Saner C, Greuter T, et al. Sex impacts disease activity but not symptoms or quality of life in adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2022;20:1729\u2013e17381. https:\/\/doi.org\/10.1016\/j.cgh.2021.11.009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3942_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.iac.2023.12.011","volume":"44","author":"ML van Klink","year":"2024","unstructured":"van Klink ML, Bredenoord AJ. Health-Related quality of life in patients with eosinophilic esophagitis. Immunol Allergy Clin North Am. 2024;44:265\u201380. https:\/\/doi.org\/10.1016\/j.iac.2023.12.011","journal-title":"Immunol Allergy Clin North Am"},{"key":"3942_CR27","doi-asserted-by":"publisher","unstructured":"Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C, et al. Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets. Front Physiol. 2022;12. https:\/\/doi.org\/10.3389\/fphys.2021.815842","DOI":"10.3389\/fphys.2021.815842"},{"key":"3942_CR28","doi-asserted-by":"publisher","first-page":"e29993","DOI":"10.1097\/MD.0000000000029993","volume":"101","author":"S Assassi","year":"2022","unstructured":"Assassi S, Shao N, Yin Z, Volkmann ER, Zoz DF, Leonard TB. Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a retrospective cohort study. Medicine. 2022;101:e29993. https:\/\/doi.org\/10.1097\/MD.0000000000029993","journal-title":"Medicine"},{"key":"3942_CR29","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/x3s9td","author":"NN Kapsala","year":"2021","unstructured":"Kapsala NN, Nikolopoulos DS, Flouda SP, Chavatza AP, Tseronis DD, Aggelakos MD, et al. From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study. Clin Exp Rheumatol. 2021. https:\/\/doi.org\/10.55563\/clinexprheumatol\/x3s9td","journal-title":"Clin Exp Rheumatol"},{"key":"3942_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00508-019-1451-3","volume":"131","author":"G Novacek","year":"2019","unstructured":"Novacek G, Gr\u00f6chenig HP, Haas T, Wenzl H, Steiner P, Koch R, et al. Diagnostic delay in patients with inflammatory bowel disease in Austria. Wien Klin Wochenschr. 2019;131:104\u201312. https:\/\/doi.org\/10.1007\/s00508-019-1451-3","journal-title":"Wien Klin Wochenschr"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03942-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03942-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03942-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T18:39:18Z","timestamp":1746556758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03942-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3942"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03942-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki. This study uses a fully anonymous questionnaire. As there is no direct or indirect contact with the participants, it is not possible to identify the source of the collected data. The anonymity of the data complies with the requirements of Article 25 of the Swiss Human Research Ordinance (). Therefore, ethical approval by the local ethics committee (ethical committee canton Zurich, CH) is not required. Implied informed consent was obtained in this study, as participants were provided with an informational document outlining the study\u2019s purpose, the intended use of the data, and a statement confirming the anonymity of the collected data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.G. has consulting contracts with Sanofi-Regeneron, Janssen, BMS, Takeda, AbbVie, and Falk Pharma GmbH, received travel grants from Falk Pharma GmbH and Vifor, speaker\u2019s fee from Norgine, and an unrestricted research grant from Novartis. A.S. has consulting contracts with Celgene-Receptos, EsoCap, Falk Pharma GmbH, GSK, Novartis, Nutricia, and Sanofi-Regeneron. A.M.S. is a consultant for Falk Pharma GmbH, Adare Pharmaceuticals Inc, Celgene-Receptos, and Sanofi-Regeneron. L.B. reports fees for consulting\/advisory board from AbbVie, Amgen, BMS, MSD, Vifor, Falk, EsoCap, Janssen, Calypso, Ferring, Pfizer, Takeda, Janssen, and Sanofi. The other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"336"}}